Do Options Traders Know Something About Sotera Health Stock We Don't?
How Investors May Respond To Sotera Health Stock As Earnings Beat Holds Guidance
Sotera Health Company 2026 Q3 - Results - Earnings Call Presentation
Sotera Health Has Favorable Setup Heading Into 2027, RBC Says
JP Morgan Maintains Underweight on Sotera Health, Lowers Price Target to $15
Barclays Maintains Overweight on Sotera Health, Lowers Price Target to $20
Sotera Health Company Q3 2026 Earnings Call Summary
Sotera Health (SHC) Q3 2026 Earnings Call Transcript
Sotera Health Co (SHC) (Q3 2026) Earnings Call Highlights: Solid Growth Amid European Med ...
What Sotera Health (SHC) Said on Its Q3 Earnings Call
Sotera Health Company (SHC) Q3 2026 Earnings Call Transcript
Sotera Health Company’s (NASDAQ:SHC) Q3 2026 sales top estimates, stock jumps 12.9%
Here's What Key Metrics Tell Us About Sotera Health (SHC) Q3 Earnings
Sotera Health Company (SHC) Beats Q3 Earnings and Revenue Estimates
Sotera Health Reports Solid Third-Quarter and Year-to-Date 2026 Results
Sotera Health Q3 2026 Earnings Call Transcript
Sotera Health Q3 Adj. EPS $0.29 Beats $0.27 Estimate, Sales $324.886M Beat $319.774M Estimate
Sotera Health Affirms FY2026 Adj EPS Guidance of $0.95-$1.01 vs $0.98 Est; Lowers FY2026 Sales Guidance from $1.236B-$1.254B to $1.233B-$1.250B vs $1.247B Est
Sotera Health Announces Third-Quarter 2026 Earnings Release Date
JP Morgan Downgrades Sotera Health to Underweight, Announces $17 Price Target
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.